The drugmaker’s current market capitalization stands at around $940 million.

“Strides has one of the best compliance standards in the Indian generic pharma industry.”

Buy Strides Shasun Ltd. at a price target of Rs 748.0 and a stop loss at Rs 696 from entry point.

Sell Strides Shasun Ltd. at a price target of Rs 668.0 and a stop loss at Rs 685 from entry point.

Buy Strides Shasun Ltd. at a price target of Rs 786.0 and a stop loss at Rs 715 from entry point.

Sell Strides Shasun Ltd. at a price target of Rs 750.0 and a stop loss at Rs 810 from entry point.

Buy Strides Shasun at a price target of Rs 835 and a stop loss at Rs 808 from entry point.

"We have a healthy pipeline and expect new product approvals to come through in the course of time."

The company will soon expand the network of retail stores, where its products are sold, to 25,000 from 20,000, said associate vice presiden...

Buy Strides Shasun Ltd. at a price target of Rs 980.0 and a stop loss at Rs 880 from entry point

The company remains committed to meeting the expectation of the authorities in the challenging regulatory landscape as it continues to evol...

The transaction is subject to customary closing conditions and expected to be closed by December 31, 2016, Strides told the Bombay Stock Ex...

Increasingly, companies are taking a deeper dive into a candidate’s mind, using psychometrics to look for a cultural fit and reject bad app...

Home appliances maker Eureka Forbes aims to double its group revenue by 2019 from the current Rs 3,200 crore with a major shift in strategy.

The deal would provide the firm a major toehold in India where the rising middle class with their disposable incomes will drive growth for ...

"Huhtamaki will acquire Positive Packaging for a debt free purchase price of EUR 247 million," an official statement said.

In developed markets, the hypermarkets are larger to start with. Some hypermarkets have as many as 60-80 check-out counters.